Global Parkinson's Disease (PD) Drugs Market Research Report 2026(Status and Outlook)
Most people with Parkinson"s disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
The global Parkinson's Disease (PD) Drugs market size was estimated at USD 5987.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Parkinson's Disease (PD) Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Parkinson's Disease (PD) Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Parkinson's Disease (PD) Drugs market.
Global Parkinson's Disease (PD) Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Market Segmentation (by Type)
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Market Segmentation (by Application)
Hospital
Family
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parkinson's Disease (PD) Drugs Market
Overview of the regional outlook of the Parkinson's Disease (PD) Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease (PD) Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Parkinson's Disease (PD) Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Parkinson's Disease (PD) Drugs market size was estimated at USD 5987.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Parkinson's Disease (PD) Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Parkinson's Disease (PD) Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Parkinson's Disease (PD) Drugs market.
Global Parkinson's Disease (PD) Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Market Segmentation (by Type)
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Market Segmentation (by Application)
Hospital
Family
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parkinson's Disease (PD) Drugs Market
Overview of the regional outlook of the Parkinson's Disease (PD) Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease (PD) Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Parkinson's Disease (PD) Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinson's Disease (PD) Drugs
1.2 Key Market Segments
1.2.1 Parkinson's Disease (PD) Drugs Segment by Type
1.2.2 Parkinson's Disease (PD) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE (PD) DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE (PD) DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Parkinson's Disease (PD) Drugs Product Life Cycle
3.3 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2020-2025)
3.4 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
3.8.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE (PD) DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE (PD) DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Parkinson's Disease (PD) Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Parkinson's Disease (PD) Drugs Market
5.7 ESG Ratings of Leading Companies
6 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2025)
6.3 Global Parkinson's Disease (PD) Drugs Market Size by Type (2020-2025)
6.4 Global Parkinson's Disease (PD) Drugs Price by Type (2020-2025)
7 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease (PD) Drugs Market Sales by Application (2020-2025)
7.3 Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2025)
8 PARKINSON'S DISEASE (PD) DRUGS MARKET SALES BY REGION
8.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region
8.2 Global Parkinson's Disease (PD) Drugs Market Size by Region
8.2.1 Global Parkinson's Disease (PD) Drugs Market Size by Region
8.2.2 Global Parkinson's Disease (PD) Drugs Market Size by Region
8.3 North America
8.3.1 North America Parkinson's Disease (PD) Drugs Sales by Country
8.3.2 North America Parkinson's Disease (PD) Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
8.4.2 Europe Parkinson's Disease (PD) Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
8.5.2 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Parkinson's Disease (PD) Drugs Sales by Country
8.6.2 South America Parkinson's Disease (PD) Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region
8.7.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PARKINSON'S DISEASE (PD) DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Parkinson's Disease (PD) Drugs by Region(2020-2025)
9.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Parkinson's Disease (PD) Drugs Production
9.4.1 North America Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.4.2 North America Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Parkinson's Disease (PD) Drugs Production
9.5.1 Europe Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Parkinson's Disease (PD) Drugs Production (2020-2025)
9.6.1 Japan Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Parkinson's Disease (PD) Drugs Production (2020-2025)
9.7.1 China Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.7.2 China Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Basic Information
10.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
10.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Market Performance
10.1.4 Boehringer Ingelheim Business Overview
10.1.5 Boehringer Ingelheim SWOT Analysis
10.1.6 Boehringer Ingelheim Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Basic Information
10.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
10.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 Novartis
10.3.1 Novartis Basic Information
10.3.2 Novartis Parkinson's Disease (PD) Drugs Product Overview
10.3.3 Novartis Parkinson's Disease (PD) Drugs Product Market Performance
10.3.4 Novartis Business Overview
10.3.5 Novartis SWOT Analysis
10.3.6 Novartis Recent Developments
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Basic Information
10.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
10.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Market Performance
10.4.4 Teva Pharmaceutical Industries Business Overview
10.4.5 Teva Pharmaceutical Industries Recent Developments
10.5 AbbVie
10.5.1 AbbVie Basic Information
10.5.2 AbbVie Parkinson's Disease (PD) Drugs Product Overview
10.5.3 AbbVie Parkinson's Disease (PD) Drugs Product Market Performance
10.5.4 AbbVie Business Overview
10.5.5 AbbVie Recent Developments
10.6 Abital Pharma
10.6.1 Abital Pharma Basic Information
10.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
10.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product Market Performance
10.6.4 Abital Pharma Business Overview
10.6.5 Abital Pharma Recent Developments
10.7 Addex Therapeutics
10.7.1 Addex Therapeutics Basic Information
10.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
10.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Market Performance
10.7.4 Addex Therapeutics Business Overview
10.7.5 Addex Therapeutics Recent Developments
10.8 Biogen
10.8.1 Biogen Basic Information
10.8.2 Biogen Parkinson's Disease (PD) Drugs Product Overview
10.8.3 Biogen Parkinson's Disease (PD) Drugs Product Market Performance
10.8.4 Biogen Business Overview
10.8.5 Biogen Recent Developments
10.9 Eisai
10.9.1 Eisai Basic Information
10.9.2 Eisai Parkinson's Disease (PD) Drugs Product Overview
10.9.3 Eisai Parkinson's Disease (PD) Drugs Product Market Performance
10.9.4 Eisai Business Overview
10.9.5 Eisai Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
10.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 F. Hoffmann-La Roche
10.11.1 F. Hoffmann-La Roche Basic Information
10.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
10.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Market Performance
10.11.4 F. Hoffmann-La Roche Business Overview
10.11.5 F. Hoffmann-La Roche Recent Developments
10.12 H. Lundbeck
10.12.1 H. Lundbeck Basic Information
10.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
10.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product Market Performance
10.12.4 H. Lundbeck Business Overview
10.12.5 H. Lundbeck Recent Developments
10.13 Impax Laboratories
10.13.1 Impax Laboratories Basic Information
10.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
10.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product Market Performance
10.13.4 Impax Laboratories Business Overview
10.13.5 Impax Laboratories Recent Developments
10.14 Kyowa Hakko Kirin
10.14.1 Kyowa Hakko Kirin Basic Information
10.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
10.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Market Performance
10.14.4 Kyowa Hakko Kirin Business Overview
10.14.5 Kyowa Hakko Kirin Recent Developments
10.15 Otsuka Pharmaceutical
10.15.1 Otsuka Pharmaceutical Basic Information
10.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
10.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Market Performance
10.15.4 Otsuka Pharmaceutical Business Overview
10.15.5 Otsuka Pharmaceutical Recent Developments
10.16 Pfizer
10.16.1 Pfizer Basic Information
10.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Overview
10.16.3 Pfizer Parkinson's Disease (PD) Drugs Product Market Performance
10.16.4 Pfizer Business Overview
10.16.5 Pfizer Recent Developments
11 PARKINSON'S DISEASE (PD) DRUGS MARKET FORECAST BY REGION
11.1 Global Parkinson's Disease (PD) Drugs Market Size Forecast
11.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region
11.2.4 South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Parkinson's Disease (PD) Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Parkinson's Disease (PD) Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2026-2035)
12.1.2 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Parkinson's Disease (PD) Drugs by Type (2026-2035)
12.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Parkinson's Disease (PD) Drugs Sales (K MT) Forecast by Application
12.2.2 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Parkinson's Disease (PD) Drugs
1.2 Key Market Segments
1.2.1 Parkinson's Disease (PD) Drugs Segment by Type
1.2.2 Parkinson's Disease (PD) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSON'S DISEASE (PD) DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Parkinson's Disease (PD) Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSON'S DISEASE (PD) DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Parkinson's Disease (PD) Drugs Product Life Cycle
3.3 Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2020-2025)
3.4 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
3.8.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PARKINSON'S DISEASE (PD) DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSON'S DISEASE (PD) DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Parkinson's Disease (PD) Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Parkinson's Disease (PD) Drugs Market
5.7 ESG Ratings of Leading Companies
6 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2025)
6.3 Global Parkinson's Disease (PD) Drugs Market Size by Type (2020-2025)
6.4 Global Parkinson's Disease (PD) Drugs Price by Type (2020-2025)
7 PARKINSON'S DISEASE (PD) DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease (PD) Drugs Market Sales by Application (2020-2025)
7.3 Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2025)
8 PARKINSON'S DISEASE (PD) DRUGS MARKET SALES BY REGION
8.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.1 Global Parkinson's Disease (PD) Drugs Sales by Region
8.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Region
8.2 Global Parkinson's Disease (PD) Drugs Market Size by Region
8.2.1 Global Parkinson's Disease (PD) Drugs Market Size by Region
8.2.2 Global Parkinson's Disease (PD) Drugs Market Size by Region
8.3 North America
8.3.1 North America Parkinson's Disease (PD) Drugs Sales by Country
8.3.2 North America Parkinson's Disease (PD) Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
8.4.2 Europe Parkinson's Disease (PD) Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
8.5.2 Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Parkinson's Disease (PD) Drugs Sales by Country
8.6.2 South America Parkinson's Disease (PD) Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region
8.7.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PARKINSON'S DISEASE (PD) DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Parkinson's Disease (PD) Drugs by Region(2020-2025)
9.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Parkinson's Disease (PD) Drugs Production
9.4.1 North America Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.4.2 North America Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Parkinson's Disease (PD) Drugs Production
9.5.1 Europe Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Parkinson's Disease (PD) Drugs Production (2020-2025)
9.6.1 Japan Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Parkinson's Disease (PD) Drugs Production (2020-2025)
9.7.1 China Parkinson's Disease (PD) Drugs Production Growth Rate (2020-2025)
9.7.2 China Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Basic Information
10.1.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
10.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Market Performance
10.1.4 Boehringer Ingelheim Business Overview
10.1.5 Boehringer Ingelheim SWOT Analysis
10.1.6 Boehringer Ingelheim Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Basic Information
10.2.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
10.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 Novartis
10.3.1 Novartis Basic Information
10.3.2 Novartis Parkinson's Disease (PD) Drugs Product Overview
10.3.3 Novartis Parkinson's Disease (PD) Drugs Product Market Performance
10.3.4 Novartis Business Overview
10.3.5 Novartis SWOT Analysis
10.3.6 Novartis Recent Developments
10.4 Teva Pharmaceutical Industries
10.4.1 Teva Pharmaceutical Industries Basic Information
10.4.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
10.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Market Performance
10.4.4 Teva Pharmaceutical Industries Business Overview
10.4.5 Teva Pharmaceutical Industries Recent Developments
10.5 AbbVie
10.5.1 AbbVie Basic Information
10.5.2 AbbVie Parkinson's Disease (PD) Drugs Product Overview
10.5.3 AbbVie Parkinson's Disease (PD) Drugs Product Market Performance
10.5.4 AbbVie Business Overview
10.5.5 AbbVie Recent Developments
10.6 Abital Pharma
10.6.1 Abital Pharma Basic Information
10.6.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
10.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Product Market Performance
10.6.4 Abital Pharma Business Overview
10.6.5 Abital Pharma Recent Developments
10.7 Addex Therapeutics
10.7.1 Addex Therapeutics Basic Information
10.7.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
10.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Market Performance
10.7.4 Addex Therapeutics Business Overview
10.7.5 Addex Therapeutics Recent Developments
10.8 Biogen
10.8.1 Biogen Basic Information
10.8.2 Biogen Parkinson's Disease (PD) Drugs Product Overview
10.8.3 Biogen Parkinson's Disease (PD) Drugs Product Market Performance
10.8.4 Biogen Business Overview
10.8.5 Biogen Recent Developments
10.9 Eisai
10.9.1 Eisai Basic Information
10.9.2 Eisai Parkinson's Disease (PD) Drugs Product Overview
10.9.3 Eisai Parkinson's Disease (PD) Drugs Product Market Performance
10.9.4 Eisai Business Overview
10.9.5 Eisai Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
10.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 F. Hoffmann-La Roche
10.11.1 F. Hoffmann-La Roche Basic Information
10.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
10.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Market Performance
10.11.4 F. Hoffmann-La Roche Business Overview
10.11.5 F. Hoffmann-La Roche Recent Developments
10.12 H. Lundbeck
10.12.1 H. Lundbeck Basic Information
10.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
10.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Product Market Performance
10.12.4 H. Lundbeck Business Overview
10.12.5 H. Lundbeck Recent Developments
10.13 Impax Laboratories
10.13.1 Impax Laboratories Basic Information
10.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
10.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Product Market Performance
10.13.4 Impax Laboratories Business Overview
10.13.5 Impax Laboratories Recent Developments
10.14 Kyowa Hakko Kirin
10.14.1 Kyowa Hakko Kirin Basic Information
10.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
10.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Market Performance
10.14.4 Kyowa Hakko Kirin Business Overview
10.14.5 Kyowa Hakko Kirin Recent Developments
10.15 Otsuka Pharmaceutical
10.15.1 Otsuka Pharmaceutical Basic Information
10.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
10.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Market Performance
10.15.4 Otsuka Pharmaceutical Business Overview
10.15.5 Otsuka Pharmaceutical Recent Developments
10.16 Pfizer
10.16.1 Pfizer Basic Information
10.16.2 Pfizer Parkinson's Disease (PD) Drugs Product Overview
10.16.3 Pfizer Parkinson's Disease (PD) Drugs Product Market Performance
10.16.4 Pfizer Business Overview
10.16.5 Pfizer Recent Developments
11 PARKINSON'S DISEASE (PD) DRUGS MARKET FORECAST BY REGION
11.1 Global Parkinson's Disease (PD) Drugs Market Size Forecast
11.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region
11.2.4 South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Parkinson's Disease (PD) Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Parkinson's Disease (PD) Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2026-2035)
12.1.2 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Parkinson's Disease (PD) Drugs by Type (2026-2035)
12.2 Global Parkinson's Disease (PD) Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Parkinson's Disease (PD) Drugs Sales (K MT) Forecast by Application
12.2.2 Global Parkinson's Disease (PD) Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 4. Global Parkinson's Disease (PD) Drugs Market Size by Application
Table 5. Parkinson's Disease (PD) Drugs Market Size Comparison by Region (M USD)
Table 6. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2025)
Table 11. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease (PD) Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 27. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 28. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Parkinson's Disease (PD) Drugs Market Share by Type (2020-2025)
Table 32. Global Parkinson's Disease (PD) Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Application
Table 34. Global Parkinson's Disease (PD) Drugs Market Size by Application
Table 35. Global Parkinson's Disease (PD) Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Parkinson's Disease (PD) Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Parkinson's Disease (PD) Drugs Market Share by Application (2020-2025)
Table 39. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025)
Table 44. North America Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Parkinson's Disease (PD) Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Parkinson's Disease (PD) Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Parkinson's Disease (PD) Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Parkinson's Disease (PD) Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Boehringer Ingelheim Basic Information
Table 63. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
Table 64. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim SWOT Analysis
Table 67. Boehringer Ingelheim Recent Developments
Table 68. GlaxoSmithKline Basic Information
Table 69. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
Table 70. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline SWOT Analysis
Table 73. GlaxoSmithKline Recent Developments
Table 74. Novartis Basic Information
Table 75. Novartis Parkinson's Disease (PD) Drugs Product Overview
Table 76. Novartis Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Novartis Business Overview
Table 78. Novartis SWOT Analysis
Table 79. Novartis Recent Developments
Table 80. Teva Pharmaceutical Industries Basic Information
Table 81. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
Table 82. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Teva Pharmaceutical Industries Business Overview
Table 84. Teva Pharmaceutical Industries Recent Developments
Table 85. AbbVie Basic Information
Table 86. AbbVie Parkinson's Disease (PD) Drugs Product Overview
Table 87. AbbVie Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AbbVie Business Overview
Table 89. AbbVie Recent Developments
Table 90. Abital Pharma Basic Information
Table 91. Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
Table 92. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Abital Pharma Business Overview
Table 94. Abital Pharma Recent Developments
Table 95. Addex Therapeutics Basic Information
Table 96. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
Table 97. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Addex Therapeutics Business Overview
Table 99. Addex Therapeutics Recent Developments
Table 100. Biogen Basic Information
Table 101. Biogen Parkinson's Disease (PD) Drugs Product Overview
Table 102. Biogen Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Biogen Business Overview
Table 104. Biogen Recent Developments
Table 105. Eisai Basic Information
Table 106. Eisai Parkinson's Disease (PD) Drugs Product Overview
Table 107. Eisai Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eisai Business Overview
Table 109. Eisai Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
Table 112. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. F. Hoffmann-La Roche Basic Information
Table 116. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
Table 117. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. F. Hoffmann-La Roche Business Overview
Table 119. F. Hoffmann-La Roche Recent Developments
Table 120. H. Lundbeck Basic Information
Table 121. H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
Table 122. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. H. Lundbeck Business Overview
Table 124. H. Lundbeck Recent Developments
Table 125. Impax Laboratories Basic Information
Table 126. Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
Table 127. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Impax Laboratories Business Overview
Table 129. Impax Laboratories Recent Developments
Table 130. Kyowa Hakko Kirin Basic Information
Table 131. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
Table 132. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Kyowa Hakko Kirin Business Overview
Table 134. Kyowa Hakko Kirin Recent Developments
Table 135. Otsuka Pharmaceutical Basic Information
Table 136. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
Table 137. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Otsuka Pharmaceutical Business Overview
Table 139. Otsuka Pharmaceutical Recent Developments
Table 140. Pfizer Basic Information
Table 141. Pfizer Parkinson's Disease (PD) Drugs Product Overview
Table 142. Pfizer Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Pfizer Business Overview
Table 144. Pfizer Recent Developments
Table 145. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Parkinson's Disease (PD) Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Parkinson's Disease (PD) Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 4. Global Parkinson's Disease (PD) Drugs Market Size by Application
Table 5. Parkinson's Disease (PD) Drugs Market Size Comparison by Region (M USD)
Table 6. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2025)
Table 11. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinson's Disease (PD) Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Parkinson's Disease (PD) Drugs Sales by Type (K MT)
Table 27. Global Parkinson's Disease (PD) Drugs Market Size by Type (M USD)
Table 28. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Parkinson's Disease (PD) Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Parkinson's Disease (PD) Drugs Market Share by Type (2020-2025)
Table 32. Global Parkinson's Disease (PD) Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Parkinson's Disease (PD) Drugs Sales (K MT) by Application
Table 34. Global Parkinson's Disease (PD) Drugs Market Size by Application
Table 35. Global Parkinson's Disease (PD) Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Parkinson's Disease (PD) Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Parkinson's Disease (PD) Drugs Market Share by Application (2020-2025)
Table 39. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025)
Table 44. North America Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Parkinson's Disease (PD) Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Parkinson's Disease (PD) Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Parkinson's Disease (PD) Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Parkinson's Disease (PD) Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Parkinson's Disease (PD) Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Parkinson's Disease (PD) Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Boehringer Ingelheim Basic Information
Table 63. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Overview
Table 64. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Boehringer Ingelheim Business Overview
Table 66. Boehringer Ingelheim SWOT Analysis
Table 67. Boehringer Ingelheim Recent Developments
Table 68. GlaxoSmithKline Basic Information
Table 69. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Overview
Table 70. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline SWOT Analysis
Table 73. GlaxoSmithKline Recent Developments
Table 74. Novartis Basic Information
Table 75. Novartis Parkinson's Disease (PD) Drugs Product Overview
Table 76. Novartis Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Novartis Business Overview
Table 78. Novartis SWOT Analysis
Table 79. Novartis Recent Developments
Table 80. Teva Pharmaceutical Industries Basic Information
Table 81. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Overview
Table 82. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Teva Pharmaceutical Industries Business Overview
Table 84. Teva Pharmaceutical Industries Recent Developments
Table 85. AbbVie Basic Information
Table 86. AbbVie Parkinson's Disease (PD) Drugs Product Overview
Table 87. AbbVie Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AbbVie Business Overview
Table 89. AbbVie Recent Developments
Table 90. Abital Pharma Basic Information
Table 91. Abital Pharma Parkinson's Disease (PD) Drugs Product Overview
Table 92. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Abital Pharma Business Overview
Table 94. Abital Pharma Recent Developments
Table 95. Addex Therapeutics Basic Information
Table 96. Addex Therapeutics Parkinson's Disease (PD) Drugs Product Overview
Table 97. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Addex Therapeutics Business Overview
Table 99. Addex Therapeutics Recent Developments
Table 100. Biogen Basic Information
Table 101. Biogen Parkinson's Disease (PD) Drugs Product Overview
Table 102. Biogen Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Biogen Business Overview
Table 104. Biogen Recent Developments
Table 105. Eisai Basic Information
Table 106. Eisai Parkinson's Disease (PD) Drugs Product Overview
Table 107. Eisai Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eisai Business Overview
Table 109. Eisai Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Parkinson's Disease (PD) Drugs Product Overview
Table 112. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. F. Hoffmann-La Roche Basic Information
Table 116. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Overview
Table 117. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. F. Hoffmann-La Roche Business Overview
Table 119. F. Hoffmann-La Roche Recent Developments
Table 120. H. Lundbeck Basic Information
Table 121. H. Lundbeck Parkinson's Disease (PD) Drugs Product Overview
Table 122. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. H. Lundbeck Business Overview
Table 124. H. Lundbeck Recent Developments
Table 125. Impax Laboratories Basic Information
Table 126. Impax Laboratories Parkinson's Disease (PD) Drugs Product Overview
Table 127. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Impax Laboratories Business Overview
Table 129. Impax Laboratories Recent Developments
Table 130. Kyowa Hakko Kirin Basic Information
Table 131. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Overview
Table 132. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Kyowa Hakko Kirin Business Overview
Table 134. Kyowa Hakko Kirin Recent Developments
Table 135. Otsuka Pharmaceutical Basic Information
Table 136. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Overview
Table 137. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Otsuka Pharmaceutical Business Overview
Table 139. Otsuka Pharmaceutical Recent Developments
Table 140. Pfizer Basic Information
Table 141. Pfizer Parkinson's Disease (PD) Drugs Product Overview
Table 142. Pfizer Parkinson's Disease (PD) Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Pfizer Business Overview
Table 144. Pfizer Recent Developments
Table 145. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Parkinson's Disease (PD) Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Parkinson's Disease (PD) Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Parkinson's Disease (PD) Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Parkinson's Disease (PD) Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease (PD) Drugs Market Size (M USD), 2025-2035
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Parkinson's Disease (PD) Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease (PD) Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Parkinson's Disease (PD) Drugs Product Life Cycle
Figure 13. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2025
Figure 15. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2025
Figure 18. Industry Chain Map of Parkinson's Disease (PD) Drugs
Figure 19. Global Parkinson's Disease (PD) Drugs Market PEST Analysis
Figure 20. Global Parkinson's Disease (PD) Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Parkinson's Disease (PD) Drugs Market Share by Type
Figure 27. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Parkinson's Disease (PD) Drugs by Type in 2025
Figure 29. Market Share of Parkinson's Disease (PD) Drugs by Type (2020-2025)
Figure 30. Market Share of Parkinson's Disease (PD) Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Parkinson's Disease (PD) Drugs Market Share by Application
Figure 33. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2025
Figure 35. Global Parkinson's Disease (PD) Drugs Market Share by Application (2020-2025)
Figure 36. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2025
Figure 37. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025)
Figure 40. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2024
Figure 43. North America Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Parkinson's Disease (PD) Drugs Market Size by Country in 2024
Figure 45. U.S. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Parkinson's Disease (PD) Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Parkinson's Disease (PD) Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Parkinson's Disease (PD) Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Parkinson's Disease (PD) Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2024
Figure 53. Europe Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Parkinson's Disease (PD) Drugs Market Size by Country in 2024
Figure 55. Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region in 2024
Figure 68. China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 79. South America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2024
Figure 80. South America Parkinson's Disease (PD) Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Parkinson's Disease (PD) Drugs Market Size by Country in 2024
Figure 82. Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Parkinson's Disease (PD) Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Parkinson's Disease (PD) Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinson's Disease (PD) Drugs Market Size (M USD), 2025-2035
Figure 5. Global Parkinson's Disease (PD) Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Parkinson's Disease (PD) Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinson's Disease (PD) Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Parkinson's Disease (PD) Drugs Product Life Cycle
Figure 13. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2025
Figure 15. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Parkinson's Disease (PD) Drugs Revenue in 2025
Figure 18. Industry Chain Map of Parkinson's Disease (PD) Drugs
Figure 19. Global Parkinson's Disease (PD) Drugs Market PEST Analysis
Figure 20. Global Parkinson's Disease (PD) Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Parkinson's Disease (PD) Drugs Market Share by Type
Figure 27. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Parkinson's Disease (PD) Drugs by Type in 2025
Figure 29. Market Share of Parkinson's Disease (PD) Drugs by Type (2020-2025)
Figure 30. Market Share of Parkinson's Disease (PD) Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Parkinson's Disease (PD) Drugs Market Share by Application
Figure 33. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2025
Figure 35. Global Parkinson's Disease (PD) Drugs Market Share by Application (2020-2025)
Figure 36. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2025
Figure 37. Global Parkinson's Disease (PD) Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Parkinson's Disease (PD) Drugs Market Size by Region (2020-2025)
Figure 40. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2024
Figure 43. North America Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Parkinson's Disease (PD) Drugs Market Size by Country in 2024
Figure 45. U.S. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Parkinson's Disease (PD) Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Parkinson's Disease (PD) Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Parkinson's Disease (PD) Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Parkinson's Disease (PD) Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2024
Figure 53. Europe Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Parkinson's Disease (PD) Drugs Market Size by Country in 2024
Figure 55. Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Parkinson's Disease (PD) Drugs Market Size by Region in 2024
Figure 68. China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 79. South America Parkinson's Disease (PD) Drugs Sales Market Share by Country in 2024
Figure 80. South America Parkinson's Disease (PD) Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Parkinson's Disease (PD) Drugs Market Size by Country in 2024
Figure 82. Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Parkinson's Disease (PD) Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Parkinson's Disease (PD) Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Parkinson's Disease (PD) Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Parkinson's Disease (PD) Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Parkinson's Disease (PD) Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Parkinson's Disease (PD) Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2026-2035)
